+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rotavirus Drug"

Rotavirus infections - Pipeline Insight, 2024 - Product Thumbnail Image

Rotavirus infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Rotavirus Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Rotavirus Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 58 Pages
  • Global
From
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Rotavirus Drug market is a subset of the larger Infectious Diseases Drugs market. Rotavirus is a virus that causes severe diarrhea, vomiting, fever, and abdominal pain in infants and young children. Rotavirus is the most common cause of severe diarrhea in young children, and is responsible for the deaths of hundreds of thousands of children each year. Vaccines are the most effective way to prevent rotavirus infection, but there are also several drugs available to treat the infection. These drugs work by targeting the virus itself, or by reducing the symptoms of the infection. The Rotavirus Drug market is highly competitive, with several major players offering a range of products. Companies in the market include Merck, GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. Show Less Read more